IndustryIntelligence | Biotechnology & Drugs

The Consus Group provides critical intelligence for the
business, investor, and legal communities.

Documents can be downloaded immediately after purchase. Complete your order by clicking the Add-to-Cart button.

$37	Subscribers Preview	2002	Addendum to Sublicense Agreement	BioDelivery Sciences International Inc.	BioDelivery Sciences, Inc.
$37	Subscribers Preview	2002	Addendum to Sublicense Agreement	BioDelivery Sciences International Inc.	BioDelivery Sciences, Inc.
$39	Subscribers Preview	2002	Adjusted License Agreement	Cordis Corporation; J&J	SurModics
$39	Subscribers Preview	2002	Affiliation and Distribution Agreement	Ribapharm Inc; ICN Pharmaceuticals, Inc.; Schering-Plough	Schering-Plough; ISDA
$46	Subscribers Preview	2002	Affiliation and Distribution Agreement	Ribapharm Inc; ICN Pharmaceuticals, Inc.; Schering-Plough	Schering-Plough; ISDA
$74	Subscribers Preview	2002	Agreement	OrthoBiotech; Biogen; Curis	Eli Lilly 2 3 4 5 6
$39	Subscribers Preview	2004	Agreement	Wyeth	Xcyte Therapies, Inc.
$69	Subscribers Preview	2000	Agreement for the License and Supply of Terminators	Nen Life Science Products, Inc.; Orchid Biocomputer, Inc.	Orchid; Mintz Levin
$43	Subscribers Preview	2003	Agreement on Cooperative Research and Development	Institute of Experimental Botany	Senetek plc
$38	Subscribers Preview	2003	Agreement Regarding Sublicenses	Corixa Corp.; Dana-Farber Cancer Institute, Inc.; Coulter Corporation	Coulter Pharma; Michigan; Cooley Godward
$38	Subscribers Preview	2003	Applications Research Agreement	Kubota Corp.	Paracelsian, Inc.
$57	Subscribers Preview	2003	Asset Purchase and License Agreement	Restoragen Inc; Amylin Pharma	Cooley Godward
$53	Subscribers Preview	2003	Asset Purchase and License Agreement	Restoragen Inc; Coolidge & Company, Inc.	Amylin Pharma; NPS Pharma
$50	Subscribers Preview	2003	Asset Purchase and License Agreement	Amylin Pharma; NPS Pharma	Restoragen
$45	Subscribers Preview	2003	Asset Purchase and License Agreement	Amylin Pharmaceuticals Inc.	Restoragen Inc
$50	Subscribers Preview	2005	Asset Purchase and License Agreement	BioCryst Pharmaceuticals, Inc.	Tanox, Inc.
$49	Subscribers Preview	2004	Asset Purchase and Product Development Agreement	CollaGenex Pharmaceuticals Inc.
$67	Subscribers Preview	2003	Asset Transfer and License Agreement	Genentech; Guilford Pharma	Merck
$40	Subscribers Preview	2002	Asset Transfer and Sublicense Agreement	Enchira Biotechnology Corp	Maxygen, Inc.
$42	Subscribers Preview	2002	Asset Transfer and Sublicense Agreement	Enchira Biotechnology Corp	Maxygen, Inc.